Martin Reck, MD, PhD; Lung Clinic Grosshansdorf 5Live #ASCO20
3:43
Key insights on Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA.
Non Small Cell Lung Cancer
Martin Reck, MD, PhD; Lung Clinic Grosshansdorf 5Live #ASCO20
Key insights on Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA.
Non Small Cell Lung Cancer Similar Videos
Similar Videos
